Impact of Carotid Artery Angioplasty in Symptomatic vs. Asymptomatic Carotid Artery Disease
DOI:
https://doi.org/10.22317/jcms.v11i4.1974Keywords:
Angioplasty, Carotid Arteries, Stroke, Atherosclerosis.Abstract
Objectives: To compare the procedural success as well as periprocedural complications and short-term clinical outcomes on CAS in symptomatic versus asymptomatic patients who have severe carotid artery stenosis.
Methods: This study is an observational, single center, prospective cohort study of 250 patients with a mean age of 74±7.2 years who underwent CAS from 2018 to 2024 in a tertiary cardiovascular center, classified into two groups: symptomatic(n=146), and asymptomatic(n=104). Technical success, early complications within thirty days, restenosis, late stroke, and six-month event-free survival were analyzed.
Results: There was technical success achieved in about 98.3% of the population under study (n = 246), while major stroke of early onset was recorded at about 1.6%. Minor stroke/TIA was recorded at about 4.8% percent with a higher percentage among the symptomatic. There were no myocardial infarctions. More than 50% restenosis at 6 months follow-up was noted in 6.8% with an event-free survival of 90%, better for asymptomatic patients (96% vs. 85.6%).
Conclusions: CAS produces a safe and efficient method of revascularization in the management of symptomatic and asymptomatic carotid artery stenoses with high technical success and low complication rates. Short-term results were better in asymptomatic patients; therefore, patient selection and risk stratification are very important when making decisions clinically.
References
Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612–23.
Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the ICSS. Lancet Neurol. 2010;9(4):353–62.
Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke. Stroke. 2011;42(2):517–84.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445–53.
European Carotid Surgery Trialists’ Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet. 1991;337(8752):1235–43.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–8.
Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–502.
Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361(9352):107–16.
Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351(15):1493–501.
Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with high surgical risk. Stroke. 2001;32(11):2735–40.
Kastrup A, Gröschel K, Schulz JB, Nägele T, Schmidt F, Ernemann U. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke. 2003;34(3):813–9.
Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study. Lancet. 2006;368(9543):1239–47.
Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.
Bonati LH, Dobson J, Algra A, et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet. 2010;376(9746):1062–73.
Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355(16):1660–71.
Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572–9.
White CJ, Gray WA. Carotid artery stenting: current state of evidence and future directions. Circulation. 2007;116(24):2866–74.
Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10):e573–83.
Naylor AR, Ricco JB, de Borst GJ, et al. Management of atherosclerotic carotid and vertebral artery disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(1):3–81.
Paraskevas KI, Mikhailidis DP, Veith FJ. Update on carotid stenosis and stroke prevention: review of evidence and controversies. Angiology. 2013;64(1):1–14.
Lal BK, Hobson RW 2nd, Goldstein J, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomized controlled trial. Lancet Neurol. 2012;11(9):755–63.
Schillinger M, Minar E, Dick P, et al. Risk of early restenosis after carotid artery stenting. Stroke. 2002;33(9):2230–5.
Gray WA, Hopkins LN, Yadav JS, et al. Protected carotid stenting with the ACCULINK and ACCUNET devices: 30-day results of the CAPTURE registry. Catheter Cardiovasc Interv. 2007;69(5):633–42.
Gurm HS, Yadav JS, Fayad P, et al. The Carotid Revascularization Endarterectomy vs Stenting Trial (CREST): long-term results. J Vasc Surg. 2012;55(6):1675–80.
Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol. 2011;8(2):89–99.
Parodi JC, Schonholz C, Cossman D, et al. Stroke and death rates after carotid artery stenting: a single-center experience in 628 patients. Ann Vasc Surg. 2011;25(3):310–6.
Lam RC, Chong WL, Poon CF, et al. Cerebral embolic protection devices for carotid artery stenting: a systematic review and meta-analysis. J Neurointerv Surg. 2019;11(2):117–24.
Setacci C, de Donato G, Chisci E, et al. Carotid artery stenting in the elderly: when, why, and how. Eur J Vasc Endovasc Surg. 2012;43(1):70–7.
Reimers B, Yang J, Werner M, et al. Long-term durability of carotid artery stenting: restenosis and outcomes beyond 5 years. J Endovasc Ther. 2014;21(4):480–6.
Paraskevas KI, Mikhailidis DP, Veith FJ. Carotid artery stenting for asymptomatic carotid artery stenosis: the controversy continues. Angiology. 2012;63(7):481–4.
Bosiers M, Deloose K, Verbist J, et al. Embolic protection devices during carotid artery stenting: current status and future perspectives. J Cardiovasc Surg (Torino). 2010;51(3):319–26.
Rosenfield K, Yokemick J, Mehta M, et al. Impact of operator experience on outcomes of carotid artery stenting in the CREST trial. J Am Coll Cardiol. 2017;69(24):3079–80.
Saba L, Yuan C, Hatsukami TS, et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019;18(4):305–17.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
